Literature DB >> 29577931

New Screening Techniques in Barrett's Esophagus: Great Ideas or Great Practice?

Stuart J Spechler1, David A Katzka2, Rebecca C Fitzgerald3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29577931     DOI： 10.1053/j.gastro.2018.03.031

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  13 in total

Review 1.  Role of TFF3 as an adjunct in the diagnosis of Barrett's esophagus using a minimally invasive esophageal sampling device-The CytospongeTM.

Authors:  Anna L Paterson; Marcel Gehrung; Rebecca C Fitzgerald; Maria O'Donovan
Journal:  Diagn Cytopathol       Date:  2019-12-09       Impact factor: 1.582

Review 2.  Phenotypes of Gastroesophageal Reflux Disease: Where Rome, Lyon, and Montreal Meet.

Authors:  David A Katzka; John E Pandolfino; Peter J Kahrilas
Journal:  Clin Gastroenterol Hepatol       Date:  2019-07-15       Impact factor: 11.382

Review 3.  Today's Mistakes and Tomorrow's Wisdom… In Barrett's Surveillance.

Authors:  Pauline A Zellenrath; Carlijn A M Roumans; Manon C W Spaander
Journal:  Visc Med       Date:  2022-03-01

4.  Agrin Loss in Barrett's Esophagus-Related Neoplasia and Its Utility as a Diagnostic and Predictive Biomarker.

Authors:  Vikram Deshpande; Richard O Hynes; Steffen Rickelt; Azfar Neyaz; Charlene Condon; Charles A Whittaker; Ali H Zaidi; Martin S Taylor; Genevieve Abbruzzese; Anthony R Mattia; Lawrence Zukerberg; Stuti G Shroff; Omer H Yilmaz; Osman Yilmaz; Elizabeth Y Wu; Won-Tak Choi; Blair A Jobe; Robert D Odze; Deepa T Patil
Journal:  Clin Cancer Res       Date:  2022-03-15       Impact factor: 13.801

Review 5.  Does anti-reflux surgery disrupt the pathway of Barrett's esophagus progression to cancer?

Authors:  Sebastian F Schoppmann; Ivan Kristo; Martin Riegler
Journal:  Transl Gastroenterol Hepatol       Date:  2018-12-05

6.  Nomogram predicting cancer-specific mortality in patients with esophageal adenocarcinoma: a competing risk analysis.

Authors:  Xi-Xi Wu; Ren-Pin Chen; Rui-Cong Chen; Hong-Peng Gong; Bin-Feng Wang; Ya-Ling Li; Xin-Ran Lin; Zhi-Ming Huang
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

7.  Characterization of Prevalent, Post-Endoscopy, and Incident Esophageal Cancer in the United States: A Large Retrospective Cohort Study.

Authors:  Ravy K Vajravelu; Jennifer M Kolb; Shivani U Thanawala; Frank I Scott; Samuel Han; Amit G Singal; Gary W Falk; David A Katzka; Sachin Wani
Journal:  Clin Gastroenterol Hepatol       Date:  2021-02-05       Impact factor: 13.576

Review 8.  A narrative review of Barrett's esophagus in 2020, molecular and clinical update.

Authors:  Aamir N Dam; Jason Klapman
Journal:  Ann Transl Med       Date:  2020-09

9.  Economic evaluation of Cytosponge®-trefoil factor 3 for Barrett esophagus: A cost-utility analysis of randomised controlled trial data.

Authors:  Nicholas Swart; Roberta Maroni; Beth Muldrew; Peter Sasieni; Rebecca C Fitzgerald; Stephen Morris
Journal:  EClinicalMedicine       Date:  2021-06-18

10.  Specific DNA methylation markers in the diagnosis and prognosis of esophageal cancer.

Authors:  DaPeng Li; Lei Zhang; YuPeng Liu; HongRu Sun; Justina Ucheojor Onwuka; ZhiGang Zhao; WenJing Tian; Jing Xu; YaShuang Zhao; HongYu Xu
Journal:  Aging (Albany NY)       Date:  2019-12-13       Impact factor: 5.682
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.